Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CSA C22.2 No. 80601-2-55-14:2019 – Medical Electrical Equipment: Safety and Performance of Respiratory Gas Monitors
Technical Guide to the Canadian Adoption of IEC 80601-2-55 for Respiratory Gas Monitoring Devices
Respiratory gas monitors are critical devices in anaesthesia, intensive care, and emergency medicine. In Canada, these devices must comply with CSA C22.2 No. 80601-2-55-14:2019, a national adoption of the international standard IEC 60601-2-55:2018. This article provides a technical overview of the standard’s scope, essential requirements, implementation considerations, and compliance pathway for manufacturers and healthcare technology professionals.
Scope and Application
CSA C22.2 No. 80601-2-55-14 applies to respiratory gas monitors (RGMs) used to measure gas concentrations in the respiratory gas stream of a patient. This includes but is not limited to capnometers (CO2 monitors), oxygen monitors, anaesthetic gas monitors (N2O, halogenated agents), and multi-gas analysers intended for clinical use.
The standard covers monitors that are used with a breathing circuit (mainstream or sidestream) independently or integrated into a ventilator or anaesthesia workstation. It specifies basic safety and essential performance requirements, which must be satisfied even in the presence of environmental disturbances or single-fault conditions.
Tip: This standard is not intended for laboratory analysers, mass spectrometers not directly connected to a breathing circuit, or expired gas monitors used solely for metabolic measurement outside the clinical context.
Technical Requirements and Specifications
Essential Performance
Essential performance (EP) is defined as any performance characteristic that, if impaired, would result in unacceptable risk. For RGMs, EP typically includes:
- Accuracy of gas concentration measurement under specified reference conditions and over the operating range.
- Response time (rise/fall) to a step change in gas concentration.
- Alarm system performance for high/low gas concentration limits, apnea, and technical alarms.
- Zero and calibration drift stability over time and temperature.
Performance Requirements Table
The standard defines specific accuracy limits and response times for each gas type. The following table summarises the main requirements for commonly monitored gases:
| Gas Species | Measurement Range | Accuracy (at reference conditions)* | Maximum Response Time (T90) |
|---|---|---|---|
| Carbon dioxide (CO2) | 0 – 15 % (vol) | ± (0.5 % vol + 4 % of reading) | ≤ 180 ms (mainstream) / ≤ 600 ms (sidestream)** |
| Oxygen (O2) | 0 – 100 % (vol) | ± 2 % vol (absolute) for 0–25 %; ± 3 % vol for >25 % | ≤ 600 ms |
| Nitrous oxide (N2O) | 0 – 100 % (vol) | ± (2 % vol + 4 % of reading) | ≤ 600 ms |
| Halogenated agents (e.g., sevoflurane) | 0 – 8 % (vol) | ± (0.2 % vol + 10 % of reading) for agent-specific mode | ≤ 600 ms |
* Reference conditions: 23 °C ± 2 °C, 50 % RH ± 10 %, ambient pressure 101.3 kPa ± 5 kPa.
** Sidestream monitors with a sample flow rate ≤ 200 ml/min may have longer rise times; the standard requires documentation of the actual T90.
Safety and Environmental Requirements
The standard incorporates the basic electrical safety tests of IEC 60601-1 (via CSA C22.2 No. 60601-1) and adds specific requirements:
- Protection against hazardous gas leaks – the monitor must not cause an accumulation of anaesthetic gases above occupational exposure limits.
- Water ingress protection – IP classification appropriate for cleaning and disinfection.
- Battery and power supply – if mains-fail operation is required, the monitor must function for at least 10 minutes on internal battery.
- Electromagnetic compatibility (EMC) – emissions and immunity according to IEC 60601-1-2 (ed. 4) with additional radiated immunity levels for RF surgical equipment.
Important: For monitors intended for use with flammable anaesthetics (e.g., desflurane with air/oxygen mixtures), the standard invokes IEC 60601-1-11 requirements for Home Healthcare Environment, including enhanced ESD protection and avoidance of ignition sources.
Implementation Highlights
System Design and Risk Management
Manufacturers must conduct a risk management process according to ISO 14971 (adopted as CAN/CSA-ISO 14971) and document how each hazardous situation is controlled. Particular attention is paid to:
- Sampling system integrity – sidestream monitors must prevent water condensation from affecting accuracy or controlling the sampling line heater.
- Calibration gas handling – the standard requires that calibration gases be specified and that the monitor can verify its own calibration automatically.
- Alarm prioritization – alarms for high CO2, apnea, and low oxygen must be high priority with distinct audible and visual signals.
- Single-use versus reusable components – the manufacturer must clearly label consumables and validate the cleaning/disinfection procedures.
Labeling and Instructions for Use
The standard requires that the accompanying documents include warnings and information regarding:
- Intended patient population (e.g., neonate, paediatric, adult).
- Limitations of measurement technology (e.g., sidestream not suitable for non-intubated patients with high humidity).
- Maximum sample flow rate and its effect on accuracy.
- Information on how to set alarm limits appropriate for the clinical situation.
Compliance milestone: A well-constructed risk management file can streamline the CSA certification process. Many testing laboratories will review the risk analysis as a prerequisite for performance testing.
Compliance and Certification
Testing and Validation Strategy
Before submitting for certification, the manufacturer should perform the following tests internally or with a designated third party:
- Accuracy tests using certified reference gas mixtures across the declared operating range and at the extremes of temperature/humidity.
- Response time tests with a step change from low to high concentration (e.g., 0 % to 5 % CO2) – the T90 must be verified.
- Alarm system verification – all alarm conditions must be tested, including power-up self-test, delay times, and silencing.
- EMC pre-compliance – especially immunity to high-frequency surgical diathermy (typical failure mode: false CO2 readings).
Canadian-Specific Notes
CSA C22.2 No. 80601-2-55-14 is identical to IEC 60601-2-55:2018 with no national deviations. However, compliance must be demonstrated to Health Canada as the regulator. Devices that meet this standard are generally eligible for a Medical Device Establishment License (MDEL) or Medical Device Licence (MDL) if they also meet the requirements of the Canadian Medical Devices Regulations (SOR/98-282).
Critical: Devices that have not been tested by an accredited testing organization (e.g., CSA, UL) or that lack a valid ISO 13485 quality system may face rejection at the Health Canada submission stage.
Frequently Asked Questions
Q: What types of devices are covered by CSA C22.2 No. 80601-2-55-14?
A: The standard covers all respiratory gas monitors that measure CO2, O2, N2O, and volatile anaesthetic agents in the breathing circuit of a patient, including capnometers, oxygen monitors, and multi-gas analysers used in clinical environments.
A: The standard covers all respiratory gas monitors that measure CO2, O2, N2O, and volatile anaesthetic agents in the breathing circuit of a patient, including capnometers, oxygen monitors, and multi-gas analysers used in clinical environments.
Q: Are there specific accuracy requirements for CO2 measurement?
A: Yes. For CO2, the accuracy must be within ± (0.5 % vol + 4 % of reading) over the range 0 % to 15 % vol. Additionally, the response time (T90) must not exceed 180 ms for mainstream monitors or 600 ms for sidestream monitors under specified flow conditions.
A: Yes. For CO2, the accuracy must be within ± (0.5 % vol + 4 % of reading) over the range 0 % to 15 % vol. Additionally, the response time (T90) must not exceed 180 ms for mainstream monitors or 600 ms for sidestream monitors under specified flow conditions.
Q: How does this Canadian standard relate to IEC 60601-2-55?
A: CSA C22.2 No. 80601-2-55-14 is an identical adoption of IEC 60601-2-55:2018. There are no technical differences or national deviations. Therefore, a device certified to the international version will automatically meet the Canadian standard provided it is submitted with the appropriate IEC test reports and a CSA National Differences document (if any).
A: CSA C22.2 No. 80601-2-55-14 is an identical adoption of IEC 60601-2-55:2018. There are no technical differences or national deviations. Therefore, a device certified to the international version will automatically meet the Canadian standard provided it is submitted with the appropriate IEC test reports and a CSA National Differences document (if any).
Q: Do I need additional testing for Canada beyond the IEC standard?
A: If your device is already tested to IEC 60601-2-55:2018 and you have a valid ISO 13485 certificate, you only need to show that the device complies with the Canadian Electrical Code (Part I) for any mains voltage differences (e.g., Canadian plugs and voltage ratings). Health Canada may request additional labeling for bilingual (English/French) requirements. No additional safety or performance tests are required.
A: If your device is already tested to IEC 60601-2-55:2018 and you have a valid ISO 13485 certificate, you only need to show that the device complies with the Canadian Electrical Code (Part I) for any mains voltage differences (e.g., Canadian plugs and voltage ratings). Health Canada may request additional labeling for bilingual (English/French) requirements. No additional safety or performance tests are required.
Tip: For monitors that incorporate a pulse oximeter or other combined functions, check whether additional standards (e.g., ISO 80601-2-61 for pulse oximeters) apply, as they are considered collateral or particular standards under the IEC 60601-1 family.
© 2026 Technical Overview of CSA C22.2 No. 80601-2-55-14. All rights reserved.